New Year Bumper Sale @ Rs. 1 X
Adbone k2 Tablet is an allopathic medicine The correct dosage of Adbone k2 Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Adbone k2 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Adbone k2 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Adbone k2 Tablet. It is best to stop taking Adbone k2 Tablet immediately and inform your doctor if you notice any discomfort.
Is the use of Adbone k2 Tablet safe during breastfeeding?
Adbone k2 Tablet does not show any harmful effects in lactating women.
What is the effect of Adbone k2 Tablet on the Kidneys?
Very few cases of side effects of Adbone k2 Tablet on kidney have been reported.
What is the effect of Adbone k2 Tablet on the Liver?
Using Adbone k2 Tablet does not have any harmful effects on the liver.
What is the effect of Adbone k2 Tablet on the Heart?
You can take Adbone k2 Tablet without any fear of damage to the heart.
Adbone k2 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Adbone k2 Tablet unless your doctor advises you to do so -
Is this Adbone k2 Tablet habit forming or addictive?
Adbone k2 Tablet does not cause addiction.
Interaction between Food and Adbone k2 Tablet
It is safe to take Adbone k2 Tablet with food.
Interaction between Alcohol and Adbone k2 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Adbone k2 Tablet with alcohol will be.
Yes, Adbone k2 Tablet is helpful in the treatment of post-menopausal osteoporosis (a condition in which bone become weak or brittle). Adbone k2 Tablet works in osteoporosis by increasing the calcium concentration in our body through its intestinal absorption and retention from kidneys which helps in making bones stronger.
Rarely, Adbone k2 Tablet cause a headache. It is a known side effect of this drug. However, the exact cause behind this is unknown. If you experience a severe headache after taking this drug, consider taking a mild painkiller, applying balms and complete rest even after this if the pain does not subside then discuss with your doctor immediately.
Yes, Adbone k2 Tablet can be taken with aspirin. No drug-drug interaction has been reported between them. It is safe to take Adbone k2 Tablet along with aspirin if taken as directed by the doctor. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
No, Adbone k2 Tablet should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Adbone k2 Tablet can cause metallic taste by altering the taste bud on the tongue. It is the common side effect of this drug. This effect goes away after discontinuation of the drug. If it persists even after the discontinuation of the drug, then discuss with your doctor and follow his/her instructions.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1276-1278
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 340-342
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rocaltrol® (calcitriol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Calcijex® (calcitriol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 913
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 265-269
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 655
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 800-801
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 655